Experimental Cardiology Area

Currently the experimental cardiology area includes two labs.

• The lab “Pediatric cardiomyopathies” conducts basic science studies to investigate the mechanisms underlying congenital cardiomyodistrophies in cardiomyocytes derived from induced pluripotent stem cells obtained from patients. Animal models are used to characterize the pathogenesis of the diseases for new therapies.
• The CARE-MED lab aims at developing novel techniques for myocardial repair, based on tissue engineering and on the use of extracellular vesicles, natural nanoparticles stimulating tissue regeneration. These nanoparticles will also be used as experimental therapy for congenital pediatric cardiomyopathies, establishing a collaboration and integration within the research area.